Cargando…

Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis

Imatinib is the therapeutic standard for newly diagnosed patients with chronic myeloid leukemia (CML). In these patients, imatinib has been shown to induce an apoptotic response specifically in cells expressing the oncogenic fusion protein BCR-ABL. Previous studies in our lab revealed that imatinib-...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, JING, XIAO, YUN, XIONG, HUO-MEI, LI, JING, HUANG, BO, ZHANG, HAI-BIN, FENG, DAN-QIN, CHEN, XI-MIN, WANG, XIAO-ZHONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577368/ https://www.ncbi.nlm.nih.gov/pubmed/22211240 http://dx.doi.org/10.3892/ijmm.2011.872

Ejemplares similares

Using an exon microarray to identify a global profile of gene expression and alternative splicing in K562 cells exposed to sodium valproate
por: ZHANG, XIANG-ZHONG, et al.
Publicado: (2011)

Identifying Alternative Hyper-Splicing Signatures in MG-Thymoma by Exon Arrays
por: Soreq, Lilach, et al.
Publicado: (2008)

Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays
por: Kechris, Katerina, et al.
Publicado: (2008)

Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence
por: Drullion, C, et al.
Publicado: (2012)

Overestimation of alternative splicing caused by variable probe characteristics in exon arrays
por: Gaidatzis, Dimos, et al.
Publicado: (2009)

HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells
por: Chen, Shu-Huey, et al.
Publicado: (2019)

Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells
por: Arvaniti, Katerina, et al.
Publicado: (2014)

The Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell Proliferation
por: Zhou, Ying, et al.
Publicado: (2017)

FIRMA: a method for detection of alternative splicing from exon array data
por: Purdom, E., et al.
Publicado: (2008)

Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer
por: Xi, Liqiang, et al.
Publicado: (2008)

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
por: Prado-Carrillo, Omar, et al.
Publicado: (2022)

The importance of DNA methylation of exons on alternative splicing
por: Shayevitch, Ronna, et al.
Publicado: (2018)

REMAS: a new regression model to identify alternative splicing events from exon array data
por: Zheng, Hao, et al.
Publicado: (2009)

A polymethoxyflavone from Laggera pterodonta induces apoptosis in imatinib-resistant K562R cells via activation of the intrinsic apoptosis pathway
por: Cao, Changshu, et al.
Publicado: (2014)

Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants
por: Chen, Ping, et al.
Publicado: (2011)

The effects of multiple features of alternatively spliced exons on the K(A)/K(S )ratio test
por: Chen, Feng-Chi, et al.
Publicado: (2006)

New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells
por: Oliveira, Andressa, et al.
Publicado: (2022)

Time-series analysis in imatinib-resistant chronic myeloid leukemia K562-cells under different drug treatments
por: Zhao, Yan-hong, et al.
Publicado: (2017)

Effect of exonic splicing regulation on synonymous codon usage in alternatively spliced exons of Dscam
por: Takahashi, Aya
Publicado: (2009)

The Usage of Exon-Exon Splice Junctions for the Detection of Alternative Splicing using the REIDS model
por: Van Moerbeke, Marijke, et al.
Publicado: (2018)

Alternative Splicing and Transcriptome Profiling of Experimental Autoimmune Encephalomyelitis Using Genome-Wide Exon Arrays
por: Gillett, Alan, et al.
Publicado: (2009)

Implementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis
por: Whistler, Toni, et al.
Publicado: (2010)

Comparison of Two Methods for Detecting Alternative Splice Variants Using GeneChip(®) Exon Arrays
por: Fan, Wenhong, et al.
Publicado: (2011)

Semi-random mutagenesis profile of BCR-ABL during imatinib resistance acquirement in K562 cells
por: Dong, Yan, et al.
Publicado: (2017)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Recognition of Unknown Conserved Alternatively Spliced Exons
por: Ohler, Uwe, et al.
Publicado: (2005)

Syntrophin binds to an alternatively spliced exon of dystrophin
Publicado: (1995)

Evolution of Exon-Intron Structure and Alternative Splicing
por: Koralewski, Tomasz E., et al.
Publicado: (2011)

Dissecting an alternative splicing analysis workflow for GeneChip(® )Exon 1.0 ST Affymetrix arrays
por: Della Beffa, Cristina, et al.
Publicado: (2008)

Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array
por: Gardina, Paul J, et al.
Publicado: (2006)

Protein Modularity of Alternatively Spliced Exons Is Associated with Tissue-Specific Regulation of Alternative Splicing
por: Xing, Yi, et al.
Publicado: (2005)

Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer
por: Li, Xiao-Wei, et al.
Publicado: (2015)

The Emergence of Alternative 3′ and 5′ Splice Site Exons from Constitutive Exons
por: Koren, Eli, et al.
Publicado: (2007)

The Mechanism of Bufalin-Induced Apoptosis of K562/A02
por: Xie, Ying, et al.
Publicado: (2019)

Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
por: Lee, Yueh-Lun, et al.
Publicado: (2013)

Mutations primarily alter the inclusion of alternatively spliced exons
por: Baeza-Centurion, Pablo, et al.
Publicado: (2020)

Tandem Exon Duplications Expanding the Alternative Splicing Repertoire
por: Ivanov, T. M., et al.
Publicado: (2022)

Splice site proximity influences alternative exon definition
por: Carranza, Francisco, et al.
Publicado: (2022)

Establishment and molecular characterization of decitabine‐resistant K562 cells
por: Wen, Xiang‐Mei, et al.
Publicado: (2019)

Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca(2+)-dependent gap junction intercellular communication
por: Li, Xiaoping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j0cr7dag3icg412nkpihqi882n